(Reuters) -Johnson & Johnson said on Tuesday it will withdraw a device to treat acid reflux disease from certain markets outside the United States, citing commercial reasons. The company has decided ...

Surgeons place it around the lower part of the esophagus to help prevent stomach acid from flowing back up, which causes ...

Mayo Clinic in Jacksonville, Fla., has announced it will be one of the first healthcare organizations in the United States to offer the LINX Reflux Management System to treat gastroesophageal reflux ...

Johnson & Johnson subsidiary Ethicon and medical device company Torax Medical were hit with a cluster of product liability lawsuits this past week in Minnesota federal court. Three new suits allege ...

One in five Americans suffers from gastroesophageal reflux disease (GERD), known colloquially as acid reflux. Acid reflux is a digestive disorder in in which acid backs up from the stomach into the ...

Johnson & Johnson (NYSE:JNJ) is one of the best conservative stocks to buy now. On September 23, the company announced plans to withdraw the LINX Reflux Management System in certain countries. The ...